Kurome Therapeutics
Latest round
- Series A
Last raised
- Jun 2021
Total raised
- $15M
Investors
- 3
About Kurome Therapeutics
Based in Ohio, US, and founded in 2019, Kurome Therapeutics operates as a pre-clinical stage company that focuses on developing targeted kinase inhibitors for patients with hematological cancers. Kurome Therapeutics develops a series of IRAK-4 (interleukin-1 receptor-associated kinase 4) and panFLT3 inhibitors to target adaptive resistance mechanisms in cancer cells. The company also helps to improve the outcome of patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Who invested in Kurome Therapeutics
3 investors across 2 rounds
See all investors in Kurome Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kurome Therapeutics
Who invested in Kurome Therapeutics?
Kurome Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kurome Therapeutics raised?
Kurome Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Kurome Therapeutics last raise money?
Kurome Therapeutics's most recent round on record is a Series A, in Jun 2021.
What does Kurome Therapeutics do?
Based in Ohio, US, and founded in 2019, Kurome Therapeutics operates as a pre-clinical stage company that focuses on developing targeted kinase inhibitors for patients with hematological cancers.
Where is Kurome Therapeutics headquartered?
Kurome Therapeutics is headquartered in Cincinnati, US.
Which VCs invest in companies like Kurome Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kurome Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Kurome Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.